ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc., (OTCBB:BTIM) and its wholly-owned subsidiary Embryome Sciences, Inc. announced today the launch of Embryome.com and the International Embryome Initiative, an international collaboration with scientists around the world to create the first systematic map of all the cell types derived from human embryonic stem cells. In a paper published today titled “The International Embryome Initiative: A Collaborative Database for Navigating the Complexities of Human Embryonic Stem Cell Differentiation,” available online at www.futuremedicine.com/loi/rme, BioTime and Embryome Sciences describe the collaboration to map the “embryome” in a manner similar to the international initiatives to map the human DNA or genome in the 1990s. While the database launched today at Embryome.com is currently populated with nearly 2,000 distinct cell types, the complete map will require the collective efforts of hundreds of scientists over the coming months.